Evidence map›Paper›PMID 42270745›Full record

ArticleScientific reports2026

Differentiating malignancy from liver parenchyma in Ex-Vivo OCT images using anomaly detection.

Ulrich Krispel, Alexander Pamler, Caroline Girmen, Niels König, Robert Schmitt, Eva Eggeling, Sören Büsker, Oliver Beetz, Felix Oldhafer, Daniel Truhn and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ulrich KrispelFraunhofer Austria Research GmbH, Graz, 8010, Austria.
Alexander PamlerFraunhofer Austria Research GmbH, Graz, 8010, Austria.
Caroline GirmenFraunhofer Institute for Production Technology IPT, Aachen, 52074, Germany.
Niels KönigFraunhofer Institute for Production Technology IPT, Aachen, 52074, Germany.
Robert SchmittFraunhofer Institute for Production Technology IPT, Aachen, 52074, Germany.
Eva EggelingFraunhofer Austria Research GmbH, Graz, 8010, Austria.
Sören BüskerInstitute for Pathology, University Hospital RWTH Aachen, Aachen, 52074, Germany.
Oliver BeetzDepartment of General, Visceral, Pediatric, and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, 52074, Germany.
Felix OldhaferDepartment of General, Visceral, Pediatric, and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, 52074, Germany.
Daniel TruhnDepartment of Diagnostic and Interventional Radiology, University Hospital RWTH Aachen, Aachen, 52074, Germany.
Florian W R VondranDepartment of General, Visceral, Pediatric, and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, 52074, Germany.
Iakovos AmygdalosDepartment of General, Visceral, Pediatric, and Transplantation Surgery, University Hospital RWTH Aachen, Aachen, 52074, Germany. iamygdalos@ukaachen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary liver cancer and colorectal liver metastases (CRLM) pose significant challenges, because of limited early diagnosis and the reliance on time-consuming frozen section analysis during surgery to confirm complete tumor resection (R0). This study investigates the potential of optical coherence tomography (OCT) combined with anomaly detection for differentiating hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (iCCA) and CRLM from normal liver parenchyma, ex-vivo. Our dataset comprises 173 OCT images sourced from 69 patients undergoing liver surgery. We leveraged pre-trained neural networks with frozen weights and statistical outlier modeling to train an anomaly detection model using only non-cancer parenchyma scans. Given the small-scale nature of the dataset and the presence of label uncertainty, a stratified cross-validation procedure was employed to robustly assess the model's performance in accurately matching OCT scans with their corresponding histological diagnoses. This resulted in promising classification performance using a pre-trained Vision Transformer: sensitivity 80%, specificity 78%, accuracy 79%, and area under the receiving-operating-characteristic-curve (ROC-AUC) of 81%. While limited by a relatively small and noisy dataset, this study highlights the promising potential of OCT combined with anomaly detection for intraoperative liver cancer detection. This semi-supervised learning approach offers several advantages, including reduced training time and data requirements, as well as interpretable anomaly scores.

Indexed as

Carcinoma, HepatocellularCholangiocarcinomaColorectal NeoplasmsLiverLiver NeoplasmsParenchymal TissueTomography, Optical CoherenceDiagnosis, DifferentialFemaleHumansMaleNeural Networks, ComputerROC Curve

Identifiers

PMID42270745
PMCPMC13254120

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.